ONMD Insider Trading Activity and SEC Form 4 Filings
ONMD insider trading summary
Over the past 12 months, insiders at OneMedNet Corp (ONMD) reported 9 open-market purchases worth $2.6M by 3 insiders and 6 sales worth $177K by 2 insiders on SEC Form 4. Net insider buying was $2.4M.
Latest ONMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Jeffrey Yu | Chief Medical Officer | Buy | $250K (45,126 @ $5.54) |
| Oct 7, 2026 | Thomas Kosasa | Director | Buy | $750K (129,758 @ $5.78) |
| Sep 24, 2026 | Aaron Green | Chief Executive Officer | Sell | $11K (1,667 @ $6.48) |
| Sep 22, 2026 | Aaron Green | Chief Executive Officer | Sell | $37K (5,000 @ $7.39) |
| Sep 21, 2026 | Robert Lawrence Golden | Chief Financial Officer | Sell | $20K (3,000 @ $6.63) |
| Sep 15, 2026 | Robert Lawrence Golden | Chief Financial Officer | Sell | $19K (3,000 @ $6.30) |
| Sep 14, 2026 | Robert Lawrence Golden | Chief Financial Officer | Sell | $17K (2,500 @ $6.60) |
| Sep 10, 2026 | Jeffrey Yu | Chief Medical Officer | Buy | $90K (142,857 @ $0.63) |
| Jul 30, 2026 | Thomas Kosasa | Director | Buy | $1000K (1,449,275 @ $0.69) |
| Jun 16, 2026 | Jeffrey Yu | Chief Medical Officer | Buy | $100K (172,414 @ $0.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.